Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]
Clinical trial NCT00424229 · UNKNOWN
Trial details
- NCT number
- NCT00424229
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.